{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-08-28",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20260825",
          "review_priority": "PRIORITY",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "87048",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/761416Orig1s002ltr.pdf",
              "date": "20260827",
              "type": "Letter"
            },
            {
              "id": "87053",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761416s002lbl.pdf",
              "date": "20260827",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20241120",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "80261",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2024/761416Orig1s000Lbl.pdf",
              "date": "20241121",
              "type": "Label"
            },
            {
              "id": "80553",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/761416Orig1s000Correctedltr.pdf",
              "date": "20241211",
              "type": "Letter"
            },
            {
              "id": "80557",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2024/761416Orig1s000TOC.html",
              "date": "20241212",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "3",
          "submission_status": "AP",
          "submission_status_date": "20260825",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "87049",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/761416Orig1s003ltr.pdf",
              "date": "20260827",
              "type": "Letter"
            },
            {
              "id": "87051",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761416s003lbl.pdf",
              "date": "20260827",
              "type": "Label"
            },
            {
              "id": "87052",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/761416s003lbl.pdf#page=28",
              "date": "20260827",
              "type": "Medication Guide"
            }
          ]
        }
      ],
      "application_number": "BLA761416",
      "sponsor_name": "JAZZ PHARMS",
      "openfda": {
        "application_number": [
          "BLA761416"
        ],
        "brand_name": [
          "ZIIHERA"
        ],
        "generic_name": [
          "ZANIDATAMAB-HRII"
        ],
        "manufacturer_name": [
          "Jazz Pharmaceuticals, Inc."
        ],
        "product_ndc": [
          "68727-950"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "ZANIDATAMAB"
        ],
        "spl_id": [
          "526942b1-adcb-4202-82ab-3d5eaaefc812"
        ],
        "spl_set_id": [
          "ae5d9425-fae5-4541-a158-150998343348"
        ],
        "package_ndc": [
          "68727-950-01",
          "68727-950-02"
        ],
        "nui": [
          "N0000194137",
          "N0000194138"
        ],
        "pharm_class_epc": [
          "Bispecific HER2-directed Antibody [EPC]"
        ],
        "pharm_class_moa": [
          "HER2-directed Antibody Interactions [MoA]"
        ],
        "unii": [
          "Z20OC92TDI"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "ZIIHERA",
          "active_ingredients": [
            {
              "name": "ZANIDATAMAB-HRII",
              "strength": "300MG"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "INJECTABLE",
          "route": "INJECTION",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}